s 9788 has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batel Copel, L; Bernadou, A; Chauvenet, L; Oudard, S; Pujade Lauraine, E; Thiounn, N | 1 |
| Backx, A; Bleiberg, H; De Mulder, PH; Gerard, B; Hecquet, B; Lucas, C; Punt, CJ; Tueni, E; Van Oosterom, AT; Voest, EE | 1 |
1 review(s) available for s 9788 and Kidney Neoplasms
| Article | Year |
|---|---|
[Resistance to chemotherapy in cancers of the kidney and therapeutic perspectives].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Drug Resistance, Neoplasm; Humans; Kidney Neoplasms; Piperidines; Triazines | 1995 |
1 trial(s) available for s 9788 and Kidney Neoplasms
| Article | Year |
|---|---|
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Multiple; Electrocardiography; Heart; Humans; Kidney Neoplasms; Middle Aged; Piperidines; Triazines | 1997 |